tradingkey.logo

bdx

BDX

175.310USD

-0.030-0.02%
종가 05/13, 16:00ET시세는 15분 지연됩니다
50.25B시가총액
29.09P/E TTM

bdx

175.310

-0.030-0.02%
자세한 내용은 Becton Dickinson and Co 회사
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
회사 정보
회사 코드BDX
회사 이름Becton Dickinson and Co
상장일Sep 25, 1963
설립일1906
CEOMr. Thomas E. Polen
직원 수74000
유형Ordinary Share
회계 연도 종료Sep 25
주소One Becton Drive
도시FRANKLIN LAKES
증권 거래소NYSE Consolidated
국가United States of America
우편 번호07417-1880
전화12018476800
웹사이트https://www.bd.com/
회사 코드BDX
상장일Sep 25, 1963
설립일1906
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
Mr. Michael Feld
Mr. Michael Feld
Executive Vice President, President - Life Sciences
Executive Vice President, President - Life Sciences
9.19K
+38.45%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.14K
+11.33%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+39.80%
Dr. Carrie L. Byington, M.D.
Dr. Carrie L. Byington, M.D.
Independent Director
Independent Director
5.25K
+21.54%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
754.64K
-0.32%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
59.87K
+1.58%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
47.02K
-3.86%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.81K
+6.70%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
14.21K
-8.25%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+28.43%
수익 분석
통화: USD업데이트 시간: Sun, Apr 6
통화: USD업데이트 시간: Sun, Apr 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Medication Delivery Solutions
1.12B
21.75%
Medication Management Solutions
801.00M
15.50%
Integrated Diagnostic Solutions
474.00M
9.17%
Peripheral Intervention
473.00M
9.15%
Specimen Management
462.00M
8.94%
Other
1.83B
35.49%
지역별USD
이름
수익
비율
United States
3.08B
59.58%
International
2.09B
40.42%
사업별
지역별
사업별USD
이름
수익
비율
Medication Delivery Solutions
1.12B
21.75%
Medication Management Solutions
801.00M
15.50%
Integrated Diagnostic Solutions
474.00M
9.17%
Peripheral Intervention
473.00M
9.15%
Specimen Management
462.00M
8.94%
Other
1.83B
35.49%
주주
업데이트 시간: Fri, May 9
업데이트 시간: Fri, May 9
주주 통계
유형
주주 통계
주주
비율
The Vanguard Group, Inc.
9.72%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.92%
T. Rowe Price Investment Management, Inc.
4.23%
T. Rowe Price Associates, Inc.
4.16%
Other
71.81%
주주 통계
주주
비율
The Vanguard Group, Inc.
9.72%
BlackRock Institutional Trust Company, N.A.
5.16%
State Street Global Advisors (US)
4.92%
T. Rowe Price Investment Management, Inc.
4.23%
T. Rowe Price Associates, Inc.
4.16%
Other
71.81%
유형
주주
비율
Investment Advisor
41.30%
Investment Advisor/Hedge Fund
40.98%
Pension Fund
2.79%
Research Firm
2.58%
Hedge Fund
2.51%
Bank and Trust
1.59%
Sovereign Wealth Fund
1.23%
Individual Investor
0.57%
Insurance Company
0.30%
Other
6.14%
기관 주식 보유
업데이트 시간: Sun, Jan 19
업데이트 시간: Sun, Jan 19
보고 기간
기관 수
보유 주식
비율
변동
2025Q1
2857
269.91M
94.17%
-7.84M
2024Q4
2874
271.53M
94.56%
-4.62M
2024Q3
2787
266.29M
92.14%
-3.20M
2024Q2
2782
261.01M
90.31%
-2.68M
2024Q1
2797
255.99M
88.58%
-10.13M
2023Q4
2783
259.38M
89.78%
-7.79M
2023Q3
2768
264.64M
91.23%
-591.87K
2023Q2
2787
263.29M
90.78%
-570.64K
2023Q1
2795
257.22M
90.56%
-8.75M
2022Q4
2831
255.72M
90.07%
-14.76M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
26.61M
9.27%
+188.34K
+0.71%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
14.81M
5.16%
+196.28K
+1.34%
Dec 31, 2024
State Street Global Advisors (US)
14.09M
4.91%
+134.36K
+0.96%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
12.13M
4.22%
+3.22M
+36.14%
Dec 31, 2024
T. Rowe Price Associates, Inc.
11.93M
4.15%
-1.16M
-8.84%
Dec 31, 2024
Geode Capital Management, L.L.C.
6.35M
2.21%
+66.02K
+1.05%
Dec 31, 2024
MFS Investment Management
5.45M
1.9%
+708.73K
+14.93%
Dec 31, 2024
Generation Investment Management LLP
5.82M
2.03%
-139.25K
-2.34%
Dec 31, 2024
Morgan Stanley Investment Management Ltd. (UK)
5.70M
1.98%
-310.28K
-5.16%
Dec 31, 2024
First Eagle Investment Management, L.L.C.
4.43M
1.54%
+1.06M
+31.36%
Dec 31, 2024
더 보기
관련 ETF
업데이트 시간: Fri, May 2
업데이트 시간: Fri, May 2
이름
비율
ClearBridge Dividend Strategy ESG ETF
6.5%
iShares U.S. Medical Devices ETF
4.18%
T Rowe Price Capital Appreciation Equity ETF
3.98%
T Rowe Price Value ETF
3.84%
Natixis Vaughan Nelson Select ETF
3.65%
American Century Focused Large Cap Value ETF
3.5%
First Eagle Global Equity ETF
2.82%
T Rowe Price Equity Income ETF
1.96%
Touchstone US Large Cap Focused ETF
1.86%
ProShares MSCI Transformational Changes ETF
1.84%
더 보기
ClearBridge Dividend Strategy ESG ETF
비율6.5%
iShares U.S. Medical Devices ETF
비율4.18%
T Rowe Price Capital Appreciation Equity ETF
비율3.98%
T Rowe Price Value ETF
비율3.84%
Natixis Vaughan Nelson Select ETF
비율3.65%
American Century Focused Large Cap Value ETF
비율3.5%
First Eagle Global Equity ETF
비율2.82%
T Rowe Price Equity Income ETF
비율1.96%
Touchstone US Large Cap Focused ETF
비율1.86%
ProShares MSCI Transformational Changes ETF
비율1.84%
주식 배당금
지난 5년 동안 총 5.34B USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Apr 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Jun 30, 2023 going ex on Jun 08, 2023
Jun 09, 2023
Jun 30, 2023
Jun 08, 2023
Jan 24, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Mar 31, 2023 going ex on Mar 09, 2023
Mar 10, 2023
Mar 31, 2023
Mar 09, 2023
Nov 10, 2022
BDX.NB Final Cash Dividend of gross USD 0.91 paid on Dec 30, 2022 going ex on Dec 08, 2022
Dec 09, 2022
Dec 30, 2022
Dec 08, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
tradingkey.logo
tradingkey.logo
당일 거래 데이터는 Refinitiv에서 제공하며, 이용 약관이 적용됩니다. 역사적 및 현재 종가 데이터는 Refinitiv에서 제공합니다. 모든 시세는 현지 거래소 시간 기준입니다. 미국 주식 시세의 실시간 마지막 거래 데이터는 Nasdaq을 통해 보고된 거래만 반영됩니다. 당일 거래 데이터는 최소 15분 지연되거나 거래소 요구 사항에 따라 다를 수 있습니다.
* 참고자료, 분석 및 트레이딩 전략은 제3자 제공업체인 Trading Central에서 제공하며, 분석가의 독립적인 평가와 판단에 기반한 시각으로, 투자자의 투자 목표와 재정 상황은 고려되지 않습니다.
위험 경고: 저희 웹사이트와 모바일 앱은 특정 투자 상품에 대한 일반적인 정보만을 제공합니다. Finsights는 재정적 조언이나 투자 상품에 대한 추천을 제공하지 않으며, 이러한 정보 제공이 Finsights가 금융 조언이나 추천을 제공하는 것으로 해석되어서는 안 됩니다.
투자 상품은 투자 원금 손실을 포함한 상당한 투자 위험에 노출되어 있으며, 모든 사람에게 적합하지 않을 수 있습니다. 투자 상품의 과거 성과는 미래 성과를 보장하지 않습니다.
Finsights는 제3자 광고주나 제휴사가 저희 웹사이트나 모바일 앱 또는 그 일부에 광고를 게재하거나 전달할 수 있도록 허용할 수 있으며, 사용자가 광고와 상호작용하는 방식에 따라 이들로부터 보상을 받을 수 있습니다.
© 저작권: FINSIGHTS MEDIA PTE. LTD. 모든 권리 보유